EX-4.5



 Exhibit 4.5 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR
OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED. 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER ARE SUBJECT TO A LOCKUP PERIOD OF UP TO 180 DAYS FOLLOWING THE EFFECTIVE DATE OF CERTAIN REGISTRATION
STATEMENTS OF THE COMPANY FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THIS WARRANT, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH LOCKUP
PERIOD IS BINDING ON TRANSFEREES OF THIS WARRANT. 
 WARRANT TO PURCHASE STOCK 

 

			
	Corporation:	  	FIVE 9, INC., a Delaware corporation
	Number of Shares:	  	                 (Subject to Section 1.8)
	Class of Stock:	  	Series B Preferred (Subject to Section 1.8)
	Initial Exercise Price:	  	$0.38 per share
	Issue Date:	  	August 8, 2007
	Expiration Date:	  	August 8, 2017 (Subject to Section 4.1)

 THIS WARRANT CERTIFIES THAT, for good and valuable consideration, the receipt of which is hereby acknowledged,
                         or its assignee (“Holder”) is entitled to purchase the number of fully paid and nonassessable
shares of the class of securities (the “Shares”) of the corporation (the “Company”) at the initial exercise price per Share (the “Warrant Price”) all as set forth above and as adjusted pursuant to Article 2 of this
warrant, subject to the provisions and upon the terms and conditions set forth in this warrant. 
 ARTICLE 1. EXERCISE. 

1.1 Method of Exercise. Holder may exercise this warrant by delivering this warrant and a duly executed Notice of Exercise in
substantially the form attached as Appendix 1 to the principal office of the Company. Holder shall also deliver to the Company a check for the aggregate Warrant Price for the Shares being purchase. 

1.2 Intentionally Omitted. 

1.3 Intentionally Omitted. 

1.4 Fair Market Value. If the Shares are traded regularly in a public market, the fair market value of the Shares shall be the closing
price of the Shares (or the closing price of the Company’s stock into which the Shares are convertible) reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. If the Shares are not regularly
traded in a public market, the Board of Directors of the Company shall determine fair market value in its reasonable good faith judgment. 

1.5 Delivery of Certificate and New Warrant. Promptly after Holder exercises this warrant, the Company shall deliver to Holder
certificates for the Shares acquired and, if this warrant has not been fully exercised and has not expired, a new warrant representing the Shares not so acquired. 

1.6 Replacement of Warrants. On receipt of evidence reasonable satisfactory to the Company of the loss, theft, destruction or
mutilation of this warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company, or in the case of mutilation, on surrender and cancellation of this warrant,
the Company at its expense shall execute and deliver, in lieu of this warrant, a new warrant of like tenor. 
 1.7 Repurchase on Sale,
Merger, or Consolidation of the Company. 
 1.7.1 “Acquisition.” For the purpose of this warrant,
“Acquisition” means (a) any sale, license, or other disposition of all or substantially all of the assets (including intellectual property) of the Company, or (b)







 
any reorganization, consolidation, merger or sale of the voting securities of the Company or any other transaction where the holders of the Company’s securities before the transaction
beneficially own less than 50% of the outstanding voting securities of the surviving entity after the transaction; provided that, for the purposes of (a) and (b), above, any transaction involving only the license of the Company’s
trade name or a transaction in which the Company sells or issues its equity securities to investors (or their affiliates) in the Company as of the Issue Date, shall not be deemed an Acquisition. 

1.7.2 Assumption of Warrant. If upon the closing of any Acquisition the successor entity assumes the obligations of this warrant, then
this warrant shall be exercisable for the same securities, cash, and property as would be payable for the Shares issuable upon exercise of the unexercised portion of this warrant as if such Shares were outstanding on the record date for the
Acquisition and subsequent closing. The Warrant Price shall be adjusted accordingly. The Company shall use reasonable efforts to cause the surviving corporation to assume the obligations of this warrant. 

1.7.3. Nonassumption. If upon the closing of any Acquisition the successor entity does not assume the obligations of this warrant and
Holder has not otherwise exercised this warrant, in full, then Holder shall participate in the Acquisition on the same terms as other holders of the same class of securities of the Company. 

1.8 Adjustment in Underlying Preferred Stock Price and Exercise Price. If on or before August 8, 2008, the Company sells and
issues to any investors preferred stock with aggregate gross proceeds to the Company of at least $1,400,000, this Warrant shall, concurrent with the issuance of such shares of preferred stock, automatically be adjusted to instead be exercisable for
shares of the same series and class and bearing the same rights, preferences, and privileges of such shares of stock, with the Warrant Price hereunder adjusted to equal the per share purchase price of such stock, and the number of such shares
subject to this Warrant adjusted to equal (i) Seventeen Thousand Dollars ($17,000), divided by (ii) such modified per share Warrant Price. Any adjustments made to the Warrant pursuant to this Section 1.8 shall be in addition to any
adjustments made pursuant to Article 2, below. 
 ARTICLE 2. ADJUSTMENTS TO THE SHARES. 

2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on its common stock payable in common stock, or other
securities, subdivides the outstanding common stock into a greater amount of common stock, then upon exercise of this warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which
Holder would have been entitled had Holder owned the Shares of record as of the date the dividend or subdivision occurred. 
 2.2
Reclassification, Exchange or Substitution; Automatic Exchange of Warrant. (a) Upon any reclassification, exchange, substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise
of this warrant, Holder shall be entitled to receive, upon exercise of this warrant, the number and kind of securities and property that Holder would have received for the Shares if this warrant had been exercised immediately before such
reclassification, exchange, substitution, or other event. Such an event shall include any automatic conversion of the outstanding or issuable securities of the Company of the same class or series as the Shares to common stock pursuant to the terms
of the Company’s Certificate of Incorporation upon the closing of a registered public offering of the Company’s common stock. The Company or its successor shall promptly issue to Holder a new warrant for such new securities or other
property. The new warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 2 including, without limitation, adjustments to the Warrant Price and to the number of
securities or property issuable reclassifications, exchanges substitutions, or other events. 
 (b) Immediately upon the automatic
conversion of the Company’s Series A Preferred Stock as provided under the Company’s Amended and Restated Certificate of Incorporation (any event triggering such automatic conversion of the Series A Preferred Stock is referred to as an
“Automatic Exchange Event”), Holder shall, upon no less than ten (10) business days prior written notice from the Company, deliver this warrant to the Company for cancellation and exchange upon the effectiveness of the Automatic
Exchange Event, and the Company immediately shall issue and deliver to the Holder a replacement warrant containing substantially the same terms as this warrant except that the replacement warrant shall be exercisable for that number of shares of the
Company’s 







 
common stock issuable upon conversion of all shares of Series A Preferred Stock that could be purchased by Holder upon full exercise of this Warrant on the effective date of the Automatic
Exchange Event. 
 2.3 Adjustments for Combinations, Etc. If the outstanding Shares are combined or consolidated, by reclassification
or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased. If the outstanding Shares are combined or consolidated, by reclassification or otherwise, into a greater number of shares, the Warrant Price shall be
proportionally decreased. 
 2.4 Adjustments for Diluting Issuances. The Warrant Price and the number of Shares issuable upon
exercise of this warrant shall be subject to adjustment, from time to time, in the manner set forth on Exhibit A. 
 2.5 No
Impairment. The Company shall not, by amendment of its Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or
seek to avoid the observance or performance of any of the terms to be observed or performed under this warrant by the Company, but shall at all times in good faith assist in carrying out all the provisions of this Article 2 and in taking all such
action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment. 
 2.6 Certificate as to
Adjustments. Upon each adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon
which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant Price in effect upon the date thereof and the series of adjustments leading to such Warrant Price. 

2.7 Fractional Shares. No fractional Shares shall be issuable upon exercise of the Warrant and the Number of Shares to be issued shall
be rounded down to the nearest whole Share. If a fractional share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional share interest by paying Holder amount computed by multiplying the fractional interest by
the fair market value of a full Share. 
 2.8 Shareholders’ Agreement. Holder shall execute and become a party to the
Stockholders’ Agreement dated April 20, 2004 and all Shares (and any shares of common stock issued upon conversion thereof) shall be subject to all of the terms and conditions set forth in Sections 2.2 – 2.9, 2.11, 2.12, 7 and 8
thereof. 
 ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY 

3.1 Representations and Warranties. The Company hereby represents and warrants to the Holder as follows: 

(a) The initial Warrant Price referenced on the first page of this warrant is not greater than the price at which the Shares were most recently
sold before the Issue Date. 
 (b) All Shares which may be issued upon the exercise of the purchase right represented by this warrant, and
all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or
under applicable federal and state securities laws. 
 (c) The Company’s capitalization table attached to this warrant is true and
complete as of the Issue Date. 







 3.2 Notice of Certain Events. If the Company proposes at any time (a) to declare any
dividend or distribution upon its common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or series of its stock any
additional shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; or (d) to merge or consolidate with or into any other corporation, or sell, lease, license, or
convey all or substantially all of its assets, or to liquidate, dissolve or wind up, then, in connection with each such event, the Company shall give Holder (1) at least 20 days prior written notice of the date on which a record will be taken
for such dividend, distribution, or subscription rights (and specifying the date on which the holders of common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (a) and
(b) above, and (2) in the case of the matters referred to in (c) and (d) above at least 20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of common stock will be
entitled to exchange their common stock for securities or other property deliverable upon the occurrence of such event). 
 3.3
Information Rights. So long as the Holder holds this warrant and/or any of the Shares, the Company shall deliver to the Holder (a) promptly after mailing, copies of all communiques to the shareholders of the Company, (b) within
ninety (90) days after the end of each fiscal year of the Company, the annual audited financial statements of the Company certified by independent public accountants of recognized standing and (c) within forty-five (45) days after the
end of each of the first three quarters of each fiscal year, the Company’s quarterly, unaudited financial statements. 
 3.4
Registration Under Securities Act of 1933, as amended. The Company agree that the Shares or, if the Shares are convertible into common stock of the Company, such common stock, shall be subject to the registration rights set forth on Exhibit
B. 
 ARTICLE 4. MISCELLANEOUS. 
 4.1
Terms: Notice of Expiration. This warrant is exercisable in whole or in part, at any time and from time to time on or before the Expiration Date set forth above; provided, however, that if the Company completes its initial public
offering within the three-year period immediately prior to the Expiration Date, the Expiration Date shall automatically be extended until sixty (60) days after the end of any market stand-off (or “lock-up”) period following the
effective date of the Company’s initial public offering; provided that the price per share of the Company’s common stock in the public market (the “Public Price”) is not less that the Initial Exercise Price in the event the
Public Price is less than the Initial Exercise Price prior to the Expiration Date set forth above, the Expiration Date shall automatically be extended until such time as the public Price exceeds the Initial Exercise Price. 

4.2 Legends. This warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any)
shall be imprinted with a legend in substantially the following form: 
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLE SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH
REGISTRATION IS NOT REQUIRED. 
 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER ARE SUBJECT TO A LOCKUP PERIOD OF UP TO 180 DAYS FOLLOWING
THE EFFECTIVE DATE OF CERTAIN REGISTRATION STATEMENTS OF THE COMPANY FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THIS WARRANT. A COPY OF WHICH MAY BE OBTAINED AT THE
PRINCIPAL OFFICE OF THE ISSUER, SUCH LOCKUP PERIOD IS BINDING ON TRANSFEREES OF THIS WARRANT AND THE SHARES. 
 4.3 Compliance with
Securities Laws on Transfer. This warrant and the Shares issuable upon exercise of this warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part
without compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company).
The Company shall not require Holder to provide an 







 
opinion of counsel if the transfer is to an affiliate of Holder or if there is no material question as to the availability of current information as referenced in Rule 144(c), Holder represents
that it has complied with Rule 144(d) and (e) in reasonable detail, the selling broker represents that it has complied with Rule 144(f), and the Company is provided with a copy of Holder’s notice of proposed sale. 

4.4 Transfer Procedure. Subject to the provisions of Section 4.3, Holder may transfer all or part of this warrant or the Shares
issuable upon exercise of this warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company notice of the portion of the warrant being transferred setting forth the name, address and
taxpayer identification number of the transferee and surrendering this warrant to the Company for reissuance to the transferee(s) (and Holder, if applicable); provided, however, that Holder may transfer all or part of this warrant to its affiliates,
including, without limitation, Comerica Incorporated, at any time without notice to the Company, and such affiliate shall then be entitled to all the rights of Holder under this warrant and any related agreements, and the Company shall cooperate
fully in ensuring that any stock issued upon exercise of this warrant is issued in the name of the affiliate that exercises the warrant. The terms and conditions of this warrant shall inure to the benefit of, and be binding upon, the Company and the
holders hereof and their respective permitted successors and assigns. Unless the Company is filing financial information with the SEC pursuant to the Securities Exchange Act of 1934, the Company shall have the right to refuse to transfer any portion
of this warrant to any person who directly competes with the Company. 
 4.5 Notices. All notices and other communications from the
Company to the Holder, or vice versa, shall be deemed delivered and effective when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company or the Holder, as
the case may be, in writing by the Company or such Holder from time to time. All notices to the Holder shall be addressed as follows: 
  

 
  

4.6 Amendments. This warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 
 4.7 Attorneys’
Fees. In the event of any dispute between the parties concerning the terms and provisions of this warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including
reasonable attorneys’ fees. 







 4.8 Governing Law. This warrant shall be governed by and construed in accordance with the
laws of the State of California, without giving effect to its principles regarding conflicts of law. 
  

			
	FIVE 9, INC.
		
	By:	 	 
	Name:	 	  

	Title:	 	  



  

			
	
		
	By:	 	 
	Name:	 	  

	Title:	 	  



 Authorized signatories under Corporate Resolutions to Borrow or an authorized signer(s) under a resolution covering
warrants must sign the warrant. 







 APPENDIX 1 

NOTICE OF EXERCISE 
 1. The
undersigned hereby elects to purchase _______________ shares of the ____________ stock of FIVE 9, INC. pursuant to the terms of the attached warrant, and tenders herewith payment of the purchase price of such shares in full. 

2. Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is specified
below: 
  
  

3. The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with a
view toward the resale or distribution thereof except in compliance with applicable securities laws. 

                     or Registered
Assignee 
  

	
	   

	(Signature)
	
	  

	(Date)








 EXHIBIT A 

Anti-Dilution Provisions 

(For Preferred Stock Warrants With Existing Anti-Dilution Protection) 

In the event of the issuance (a “Diluting Issuance”) by the Company, after the Issue Date of the warrant, of securities at a price
per share less than the Warrant Price, then the number of shares of common stock issuable upon conversion of the Shares shall be adjusted in accordance with those provisions (the “Provisions”) of the Company’s Certificate of
Incorporation which apply to Diluting Issuances. 
 Under no circumstances shall the aggregate Warrant Price payable by the Holder upon
exercise of the warrant increase as a result of any adjustment arising from a Diluting Issuance. 







 EXHIBIT B 

Registration Rights 
 The
Shares (if common stock), or the common stock issuable upon conversion of the Shares, shall be deemed “registrable securities” or otherwise entitled to “piggy back” registration rights in accordance with the terms of the
following agreement (the “Agreement”) between the Company and its investor(s): 
 Stockholders’ Agreement, dated as of
April 20, 2004 
 The Company agrees that no amendments will be made to the Agreement, which would have an adverse impact on
Holder’s registration rights thereunder without the consent of Holder. By acceptance of the Warrant to which the Exhibit B is attached, Holder shall be deemed to be a party to the Agreement.